Mutations of the PIK3CA gene are found in 2% to 14% of type I endometrial cancers, and increased signaling of the PI3K/AKT/mTOR pathway is associated with a poor prognosis in both type I and type II carcinomas [100]. The gene discussed is PIK3CA; the disease is endometrial cancer.